Antiphospholipid antibodies: specificity and pathophysiology (Q33491626)

27 July 2017

1 reference

title

Antiphospholipid antibodies: specificity and pathophysiology (English)

1 reference

27 July 2017

1 reference

Ronald H. W. M. Derksen

series ordinal

3

object named as

Derksen RH

1 reference

27 July 2017

de Groot PG

1

1 reference

27 July 2017

Oosting JD

series ordinal

2

1 reference

27 July 2017

publication date

1 September 1993

1 reference

Best Practice and Research: Clinical Haematology

27 July 2017

published in

1 reference

27 July 2017

volume

6

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

691-709

1 reference

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

The regulation of hemostasis: the protein C system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Familial protein S deficiency is associated with recurrent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

1 reference

7 January 2021

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

The antiphospholipid antibody dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Deficiency of protein C in congenital thrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Risk factors for thrombosis in lupus patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

On a hereditary beta-2-glycoprotein I deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Lupus anticoagulant and thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Lupus anticoagulant in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Thrombosis in patients with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Annexins: calcium-binding proteins of multi-functional importance?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980194-5

7 January 2021

10.1016/S0950-3536(05)80194-5

Identifiers

DOI

1 reference

27 July 2017

1 reference